The Convention on biological diversity "(hereinafter referred to as" the Convention ") of the parties, recalling the" Convention "article nineteenth paragraph fourth, third and eighth (g) and seventeenth, recalling also that the" Convention "conference of the parties in November 17, 1995 No. II/5 decided to ask a Biosafety Protocol, its specific emphasis is obtained by virtue of modern biotechnology, may have adverse effect on biodiversity conservation and sustainable use of any living modified organisms of the transboundary movements of problems, especially suitable to set out in advance the informed consent procedure, for consideration, the precautionary measures stipulated in" reiterated the "Rio Declaration on environment and development principle 15 the consciousness of modern biotechnology is also expanding rapidly, the public is increasingly concerned about this technology may have adverse effect on biodiversity, but also need to take account of human health A risk aware, as in the development and use of modern biotechnology and has taken to ensure that the environment and human health safety measures properly, this technique can make the human benefit, also recognize the origin center and the center of genetic diversity for humans is extremely important, considering that many countries, especially developing countries this ability is limited, difficult to cope with the change of the nature and scale of living organisms of known and potential risks, realize trade and environment agreements should complement each other, in order to achieve sustainable development, that may not be interpreted as the parties to this protocol according to the existing international agreements enjoy any rights and obligations are any change that the above statement is not to make this protocol attached to other international agreements,

Hereby agreement is as follows:

First goals

This protocol is precautionary measures according to the target of "Rio Declaration on environment and development" the 15 principles established by the assist to ensure the safe transfer, handling and use obtained by virtue of modern biological technology, may adversely affect the living modified organisms in the field to take adequate protection measures for the protection of biodiversity and sustainable use, taking into account the risks posed to human health and with particular emphasis on the problem of the transfer of the border.

Second general provisions

1 each party shall take necessary and appropriate legal, administrative and other measures for the performance of the obligations under this protocol.

2 parties should ensure that in any living modified organism development, processing, transportation, use, transfer and release, prevent or reduce the risk of biodiversity formation, but also take into account the risks posed to human health.

Any of the provisions of this Protocol shall be 3 National Sovereignty in any way interfere with the establishment in accordance with international law have on the territorial sea and the international law has on its exclusive economic zone and the continental shelf of the sovereignty and jurisdiction, nor prevent all countries ship and aircraft in accordance with international law and relevant international instruments enjoy navigation rights and freedom of navigation.

4 may not be of any of the provisions of this protocol, the explanation for the parties to ensure that restrictions on biodiversity conservation and sustainable use of the provisions of the protocol to take this more powerful action for the protection of the rights, but the condition is such action shall be in accordance with the objectives and provisions of this protocol in accordance with international law and the provisions of the parties other obligations.

5 encourages the parties to take into account the existing expertise, instruments and work undertaken by international institutions having the authority to carry out activities within the human health risk field.

Third terms

For the purpose of this protocol:

(a) "conference of parties" means the general assembly of the parties to the convention;

(b) "closed" refers to a facility, installation or other physical structure involved in the operation of any living modified organisms, and because of the influence of specific control measures of the living modified organisms that effectively limit their contact with the external environment and the external environment caused by;

(d) "exporter" means any legal person or natural person who is within the jurisdiction of the contracting contracting party and arranges to export modified living organisms;

(E) "import" means the intentional cross-border transfer from a contracting party to another contracting party;

(f) "importer" means any legal person or natural person who is within the jurisdiction of the importing contracting party and arranges to import modified living organisms;

(g) LMOs refers to any living organisms with genetic material to obtain NOVELCOMBINED of modern bio technology;

(H) "living organisms" are any biological entities that can transfer or reproduce genetic material, including organisms, viruses, and viruses that cannot reproduce;

(I) modern biotechnology refers to the application of the following techniques:

A. test tube nucleic acid technology, including the combination of deoxyribonucleic acid (DNA) and the direct injection of nucleic acids into cells or organelles, or

B. cell fusion beyond biological taxonomy,

This kind of technology can overcome the natural reproduction or re combination of obstacles, and is not used in traditional breeding and selection techniques;

(J) "regional economic integration organization" means consists of a specific region of the sovereign state of the organization, it has obtained its members to transfer this protocol pursuant to the provisions of the authority, in accordance with its internal procedures and has been duly authorized to sign, ratify, accept, approve or accede to the protocol;

(k) "crossing the border